selected publications
-
academic article
- Development of a Web-Based Interactive Tool for Visualizing Breast Cancer Clinical Trial Tolerability Data. JCO Clinical Cancer Informatics. 2024
- Comparison of Simple-Summated Scoring and Toxicity Index Scoring of Symptom Bother in the NSABP B-30 Clinical Trial. Applied Research in Quality of Life. 2023
- Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 Trial. Cancer Prevention Research. 2023
- Simulation study comparing analytical methods for single-item longitudinal patient-reported outcomes data. Quality of Life Research. 2023
- Comparison of Simple-Summated Scoring and Toxicity Index Scoring of Symptom Bother in the NSABP B-30 Clinical Trial. Applied Research in Quality of Life. 2022
- Health-related quality of life outcomes after neoadjuvant chemoradiotherapy for rectal cancer in NRG Oncology/NSABP R-04. Cancer. 2022
- Health‐related quality of life outcomes after neoadjuvant chemoradiotherapy for rectal cancer in NRG Oncology/NSABP R‐04. Cancer. 2022
- Risk factors for long-term adjuvant chemotherapy toxicity using pre-treatment host factors and self-rated treatment bother (GP5) in a clinical trial population. Cancer Research. 2022
- Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30. npj Breast Cancer. 2022
- Applying the Toxicity Index to Patient-Reported Symptom Data: An Example Using the European Organization for Research and Treatment of Cancer Colorectal Cancer-Specific Quality of Life Questionnaire. Clinical Therapeutics. 2021
- Toxicity Index, Patient-Reported Outcomes, and Early Discontinuation of Endocrine Therapy for Breast Cancer Risk Reduction in NRG Oncology/NSABP B-35. Journal of Clinical Oncology. 2021
- Evaluating Treatment Tolerability in Cancer Clinical Trials Using the Toxicity Index. JNCI: Journal of the National Cancer Institute. 2020
- Measuring the tolerability of cancer therapy: incorporating host factors as moderators of toxicity and outcomes. Quality of Life Research. 2020
- Future cancer research priorities in the USA: a Lancet Oncology Commission.. The Lancet. Oncology. 18:e653-e706. 2017
- How much do cancer-related symptoms contribute to health-related quality of life in lung and colorectal cancer patients? A report from the Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium.. Cancer. 121:2831-9. 2015
- Post-traumatic stress symptoms in cancer survivors: relationship to the impact of cancer scale and other associated risk factors. Psycho-Oncology. 2015
- Post-traumatic stress symptoms in cancer survivors: relationship to the impact of cancer scale and other associated risk factors.. Psycho-oncology. 24:643-52. 2014
- Use of imaging and biomarker tests for posttreatment care of early-stage breast cancer survivors.. Cancer. 119:4316-24. 2013
- Use of Imaging and Biomarker Tests for Posttreatment Care of Early-Stage Breast Cancer Survivors. Cancer. 2013
- The UCLA Prostate Cancer Index - Development, reliability, and validity of a health-related quality of life measure. Medical Care. 1998
- QUALITY-OF-LIFE OUTCOMES IN MEN FOR LOCALIZED PROSTATE-CANCER. JAMA. 1995
-
document
- Data from Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 Trial 2023
- Supplementary Figure S1 from Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 Trial 2023
- Supplementary Methods S1 from Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 Trial 2023
- Supplementary Table S1 from Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 Trial 2023